Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1979 1
1980 4
1981 8
1982 9
1983 6
1984 9
1985 18
1986 13
1987 22
1988 23
1989 38
1990 42
1991 18
1992 32
1993 43
1994 46
1995 56
1996 62
1997 65
1998 68
1999 90
2000 100
2001 122
2002 128
2003 195
2004 207
2005 258
2006 295
2007 332
2008 433
2009 472
2010 499
2011 621
2012 683
2013 767
2014 902
2015 1038
2016 1071
2017 1183
2018 1280
2019 1490
2020 1717
2021 2025
2022 2476
2023 2367
2024 1020

Text availability

Article attribute

Article type

Publication date

Search Results

19,873 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: jin y. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Response.
Jin Y, Kattan MW. Jin Y, et al. Chest. 2024 Apr;165(4):e131-e132. doi: 10.1016/j.chest.2023.12.017. Chest. 2024. PMID: 38599761 No abstract available.
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer.
Tong X, Patel AS, Kim E, Li H, Chen Y, Li S, Liu S, Dilly J, Kapner KS, Zhang N, Xue Y, Hover L, Mukhopadhyay S, Sherman F, Myndzar K, Sahu P, Gao Y, Li F, Li F, Fang Z, Jin Y, Gao J, Shi M, Sinha S, Chen L, Chen Y, Kheoh T, Yang W, Yanai I, Moreira AL, Velcheti V, Neel BG, Hu L, Christensen JG, Olson P, Gao D, Zhang MQ, Aguirre AJ, Wong KK, Ji H. Tong X, et al. Among authors: jin y. Cancer Cell. 2024 Mar 11;42(3):413-428.e7. doi: 10.1016/j.ccell.2024.01.012. Epub 2024 Feb 22. Cancer Cell. 2024. PMID: 38402609 Free article.
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.
Wang F, Jin Y, Wang M, Luo HY, Fang WJ, Wang YN, Chen YX, Huang RJ, Guan WL, Li JB, Li YH, Wang FH, Hu XH, Zhang YQ, Qiu MZ, Liu LL, Wang ZX, Ren C, Wang DS, Zhang DS, Wang ZQ, Liao WT, Tian L, Zhao Q, Xu RH. Wang F, et al. Among authors: jin y. Nat Med. 2024 Apr;30(4):1035-1043. doi: 10.1038/s41591-024-02813-1. Epub 2024 Mar 4. Nat Med. 2024. PMID: 38438735 Clinical Trial.
Apoptotic Vesicular Metabolism Contributes to Organelle Assembly and Safeguards Liver Homeostasis and Regeneration.
Sui B, Wang R, Chen C, Kou X, Wu D, Fu Y, Lei F, Wang Y, Liu Y, Chen X, Xu H, Liu Y, Kang J, Liu H, Kwok RTK, Tang BZ, Yan H, Wang M, Xiang L, Yan X, Zhang X, Ma L, Shi S, Jin Y. Sui B, et al. Among authors: jin y. Gastroenterology. 2024 Feb 10:S0016-5085(24)00136-7. doi: 10.1053/j.gastro.2024.02.001. Online ahead of print. Gastroenterology. 2024. PMID: 38342194
Carbon emission prediction models: A review.
Jin Y, Sharifi A, Li Z, Chen S, Zeng S, Zhao S. Jin Y, et al. Sci Total Environ. 2024 Jun 1;927:172319. doi: 10.1016/j.scitotenv.2024.172319. Epub 2024 Apr 9. Sci Total Environ. 2024. PMID: 38599410 Review.
The potential role of hydrogen sulfide in cancer cell apoptosis.
Gao W, Liu YF, Zhang YX, Wang Y, Jin YQ, Yuan H, Liang XY, Ji XY, Jiang QY, Wu DD. Gao W, et al. Among authors: jin yq. Cell Death Discov. 2024 Mar 6;10(1):114. doi: 10.1038/s41420-024-01868-w. Cell Death Discov. 2024. PMID: 38448410 Free PMC article. Review.
Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13+CD103+CD8+ Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy.
Hu C, You W, Kong D, Huang Y, Lu J, Zhao M, Jin Y, Peng R, Hua D, Kuang DM, Chen Y. Hu C, et al. Among authors: jin y. Gastroenterology. 2023 Oct 29:S0016-5085(23)05198-3. doi: 10.1053/j.gastro.2023.10.022. Online ahead of print. Gastroenterology. 2023. PMID: 38445519 Free article.
19,873 results
You have reached the last available page of results. Please see the User Guide for more information.